Efficacy, Safety and Responder Subanalysis of Lenalidomide in Heavily Pretreated, Relapsed/Refractory Patients With Mantle Cell Lymphoma Post-Bortezomib: Phase II MCL-001 "EMERGE" Study

---

Goy A., Williams M. E., Besisik S., Drach J., Ramchandren R., Zhang L., ...More

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, vol.14, 2014 (SCI-Expanded, Scopus)

• Publication Type: Article / Abstract
• Volume: 14
• Publication Date: 2014
• Doi Number: 10.1016/j.clml.2014.06.077
• Journal Name: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Istanbul University Affiliated: Yes